As of 3:59pm ET
| +0.1581 / +19.96%|
The 1 analysts offering 12-month price forecasts for Opexa Therapeutics Inc have a median target of 1.00, with a high estimate of 1.00 and a low estimate of 1.00. The median estimate represents a +5.26% increase from the last price of 0.95.
The current consensus among 1 polled investment analysts is to Hold stock in Opexa Therapeutics Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.